Olmesartan medoxomil/hydrochlorothiazide Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Hypertension and heart failure | Cardiovascular System
Items (12m)
11
Total Quantity
308
NHS Cost
£135
vs National Avg
+11%
MAPLE ACCESS PARTNERSHIP LLP prescribed 11 items of Olmesartan medoxomil/hydrochlorothiazide over the last 12 months at a cost of £135 to the NHS. This is 11% above the national average prescribing rate. Olmesartan medoxomil/hydrochlorothiazide is classified under Hypertension and heart failure in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 11 |
|---|---|
| Total Quantity | 308 |
| Total NHS Cost | £135 |
| Presentations | 1 different forms |
| vs National Average | +11% |
Olmesartan medoxomil/hydrochlorothiazide Prescribing Comparison
| This practice | 11 items |
|---|---|
| National average per practice | 10 items |
| Difference | +11% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.